Can supreme™ laryngeal mask airway be an alternative to endotracheal intubation in laparoscopic surgery?

Aydoğmuş, Meltem Türkay; Türk, Hacer Şebnem; Oba, Sibel; Ünsal, Oya; Sınıkoglu, Sıtkı Nadir

doi:10.1016/j.bjane.2012.12.008

Cited by 13 publications

(9 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These include decreased hemodynamic stress, improved emergence characteristics like less cough, sore throat and dysphagia. Decreased PONV and post operative opiate consumption has also been reported but larger numbers have to be studied to prove this benefit [31,33,45].…”

Section: Both Effective Airway Devicesmentioning

confidence: 99%

Supraglottic Devices in Laparoscopic Surgery - A Review of Literature

Subramanian¹

2016

ACC

View full text Add to dashboard Cite

Section: Both Effective Airway Devicesmentioning

confidence: 99%

Supraglottic Devices in Laparoscopic Surgery - A Review of Literature

Subramanian¹

2016

ACC

View full text Add to dashboard Cite

“…[1][2][3][4] SGDs are associated with lower haemodynamic and metabolic stress responses compared to tracheal intubation. 5,6 Increased intra-abdominal pressure from carbon dioxide (CO 2 ) pneumoperitoneum does not affect ventilation through SGDs, [7][8][9][10] and the gastric channel allows timely gastric decompression.…”

Section: Introductionmentioning

confidence: 99%

Ventilatory performance of AMBU® AuraGain™ and LMA® Supreme™ in laparoscopic surgery: A randomised controlled trial

Zhang

Drakeford

et al. 2021

Anaesth Intensive Care

View full text Add to dashboard Cite

The Ambu® AuraGain™ (Ambu A/S, Ballerup, Denmark) is a newer phthalate-free, single-use supraglottic device with the advantage of a facility for tracheal intubation if necessary intraoperatively. We compared the oropharyngeal leak pressures and other performance variables between the AMBU AuraGain and the LMA® Supreme™ (Teleflex Medical, Athlone, Co. Westmeath, Ireland) in patients undergoing laparoscopic cholecystectomy and preperitoneoscopic inguinal herniorrhaphy with carbon dioxide insufflation under controlled ventilation. We recruited 120 American Society of Anesthesiologists physical status class I–3 patients between the ages of 21 and 80 years undergoing laparoscopic cholecystectomy or preperitoneoscopic inguinal herniorrhaphy into this single-centre randomised controlled trial. The primary outcome measure was the oropharyngeal leak pressures. Secondary outcomes included insertion parameters, ventilatory characteristics and postoperative sequelae. The AuraGain had slightly but significantly higher oropharyngeal leak pressures than the LMA Supreme (mean (standard deviation) 26.1 (6.9) versus 21.4 (4.7) cmH2O, P < 0.010). The overall insertion success of the AuraGain was comparable to the LMA Supreme (AuraGain 58/60 (96.7%); LMA Supreme 56/59 (94.9%), P = 0.679). The AuraGain was deemed more difficult to insert than the LMA Supreme, with 26/60 (43.3%) of AuraGain insertions graded easy versus 48/59 (81.4%) of LMA Supreme, P < 0.001. The mean time to insertion of the AuraGain was slightly longer than the LMA Supreme, 32.2 (10.5) versus 28.3 (12.0) s, P < 0.001. Intraoperative device failure occurred following carbon dioxide insufflation in one AuraGain and three LMA Supremes, bringing the perioperative success rate of AuraGain and LMA Supreme to 95% and 89.8%, respectively, P = 0.322. No cases of regurgitation and aspiration occurred, and minor postoperative complications were similar. The AuraGain exhibited higher oropharyngeal leak pressures than the LMA Supreme, but was slightly more difficult to insert. The higher oropharyngeal leak pressures suggest that ventilation might be less affected by high peak inspiratory pressures when using the AuraGain than the LMA Supreme.

show abstract

“…A laryngeal mask is a supraglottic ventilation device which has little noxious stimulation to the airway and may increase comfort of patients after general anesthesia 10 . The inventions of some newer laryngeal masks, like the double-tube laryngeal mask or flexible laryngeal mask, have solved the problem of misplacement or leakage which sometimes occur with traditional laryngeal masks 11 . Thus, laryngeal masks are becoming more popular.…”

Section: Introductionmentioning

confidence: 99%

Combined use of transversus abdominis plane block and laryngeal mask airway during implementing ERAS programs for patients with primary liver cancer: a randomized controlled trial

Huang

Chen

Zhu³

et al. 2020

Sci Rep

View full text Add to dashboard Cite

The incidence and mortality of primary liver cancer are very high and resection of tumor is the most crucial treatment for it. We aimed to assess the efficacy and safety of combined use of transversus abdominis plane (TAP) block and laryngeal mask airway (LMA) during implementing Enhanced Recovery After Surgery (ERAS) programs for patients with primary liver cancer. This was a prospective, evaluator-blinded, randomized, controlled parallel-arm trial. A total of 96 patients were enrolled (48 in each group). Patients in the control group received general anesthesia with endotracheal intubation, while patients in the TAP + LMA group received general anesthesia with LMA and an ultrasound-guided subcostal TAP block. The primary end-point was postoperative time of readiness for discharge. The secondary end-points were postoperative pain intensity, time to first flatus, quality of recovery (QoR), complications and overall medical cost. Postoperative time of readiness for discharge in the TAP + LMA group [7 (5–11) days] was shorter than that of the control group [8 (5–13) days, P = 0.004]. The postoperative apioid requirement and time to first flatus was lower in the TAP + LMA group [(102.8 ± 12.4) µg, (32.7 ± 5.8) h, respectively] than the control group [(135.7 ± 20.1) µg, P = 0.000; (47.2 ± 7.6) h, P = 0.000; respectively]. The QoR scores were significantly higher in the TAP + LMA group than the control group. The total cost for treatment in the TAP + LMA group [(66,608.4 ± 6,268.4) CNY] was lower than that of the control group [(84,434.0 ± 9,436.2) CNY, P = 0.000]. There was no difference in complications between these two groups. The combined usage of a TAP block and LMA is a simple, safe anesthesia method during implementing ERAS programs for patients with primary liver cancer. It can alleviate surgical stress, accelerate recovery and reduce medical cost.

show abstract

Can supreme™ laryngeal mask airway be an alternative to endotracheal intubation in laparoscopic surgery?

Abstract: SLMA can be a suitable alternative to intubation in laparoscopic surgical procedures in a group of selected patients.

Cited by 13 publications

References 20 publications

Supraglottic Devices in Laparoscopic Surgery - A Review of Literature

Supraglottic Devices in Laparoscopic Surgery - A Review of Literature

Ventilatory performance of AMBU® AuraGain™ and LMA® Supreme™ in laparoscopic surgery: A randomised controlled trial

Combined use of transversus abdominis plane block and laryngeal mask airway during implementing ERAS programs for patients with primary liver cancer: a randomized controlled trial

Contact Info

Product

Resources

About